Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.